Drug intelligence / Profile preview

[68Ga]Ga-ELI411

Development stage
Phase 1
Lead developer
Union Hospital of Huazhong University of Science and Technology
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[68Ga]Ga-ELI411 is a diagnostic radiopharmaceutical consisting of a novel small-molecule ligand, ELI411, labeled with the positron-emitting radioisotope Gallium-68. It is designed for positron emission tomography (PET) imaging of solid tumors by targeting **Fibroblast Activation Protein (FAP)**, which is highly expressed on cancer-associated fibroblasts (CAFs) within the tumor microenvironment of various malignancies. Developed by researchers at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, this tracer is being evaluated for its safety, biodistribution, and diagnostic performance. It aims to provide enhanced lesion detection and characterization compared to standard [18F]FDG PET, particularly in cancers with low glucose metabolism or in anatomical regions where high physiological FDG uptake limits sensitivity.

Other names
[68Ga]Ga-ELI-411
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on [68Ga]Ga-ELI411.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-ELI411.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call